A Clinical Study of 6MW3211 Monotherapy or Combination Therapy for AML or MDS

Clinical trial NCT05448599 · UNKNOWN

Trial details

NCT number: NCT05448599
Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Myelodysplastic Syndrome

Start date: 2022-07-08
Primary completion: 2024-06-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.